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Impact of accessory pathway ablation on the risk of atrial fibrillation
in patients with overt conduction and patients with concealed conduc-
tion over accessory pathway
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Arnaud Olivier (1), Thibaut Villemin (1), Daniel Beurrier (1), Julie Vin-
cent (1), Marc Mielczarek (1), Irina Popescu (1), Damien Voilliot (1),
Nicolas Girerd (2)
(1) CHU Nancy Brabois, Cardiologie, Vandoeuvre Les Nancy, France –
(2) INSERM, Centre d’Investigations Cliniques 9501, Vandoeuvre Les
Nancy, France
Purpose of the study: to evaluate the impact of accessory pathway (AP)
ablation on the risk of subsequent atrial fibrillation (AF) of patients with a pre-
excitation syndrome (PS) and patients with a normal ECG but with AV re-
entrant tachycardia (AVRT) over a concealed AP. 
Methods: 103 patients were studied: 93 patients, mean age 41±16 years,
with a PS presented with a well or poorly-tolerated AF (group I). They were
issued from a group of 905 patients (10%) with a PS (mean age 34±17 years).
Ten patients, mean age 50±21, with a normal ECG in sinus rhythm and with
AVRT were referred for AF (group II). They were issued from a group of 303
patients (3%) with AVRT and a normal ECG (mean age 42±18 years). Elec-
trophysiological study was performed in control state and after isoproterenol.
Patients were followed from 3 months up to 20 years.
Results: The incidence of AF at the admission was higher in PS than in
patients with concealed AP (p<0.0001). In group I, a re-entrant tachycardia
was induced in 59 patients (63%). AF was induced in 65 patients (70%). In
group II AF was induced in 4 patients (40%)(0.06). AP ablation was per-
formed in 75 group I patients (81%) and 7 group II patients (70%) (NS). After
a mean follow-up of 3±2 years, 17 group I patients (18%) presented AF recur-
rence, despite AF ablation performed in 13 of them. In patients with a PS but
without AF at admission, AF occurred only in 14 patients (2%)(p<0.0001).
Three group II patients (30%)(p<0.005) in whom AP ablation was performed
had AF recurrence. In patients with AVRT, normal ECG and no history of
AF, AF only occurred in 3% (9/293). The differences were highly significant
(p<0.0001).
Conclusions: AF incidence at the admission was higher in patients with a
PS than in patients with concealed AP (p<0.0001). After ablation, AF risk
remained higher in patients with PS and AF than in patients with PS without
AF at the admission (18 vs 2%). However the risk of recurrence of AF despite
AP ablation was lower than in patients with a concealed AP. These last
patients also remained at high risk to have AF after ablation compared to
patients with a concealed AP and without AF. 
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Incidence and predictors of new-onset atrial fibrillation in septic
shock patients in a medical ICU: data from 7-day Holter ECG moni-
toring
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Objectives: New-onset atrial fibrillation (NAF) is a common complication
of septic shock and incidence is underestimated. We sought to investigate the
real incidence, associated risk factors for NAF, and its prognostic impact
during septic shock in patients hospitalized in a medical Intensive Care Unit
(ICU). 
Design: Prospective, single-center, observational study.
Setting: Medical ICU in a large university teaching hospital.
Patients: All consecutive patients presenting between March 2011 and
May 2013 with septic shock were eligible for inclusion, with the following
exclusion criteria: patients aged <18 years, prior history of AF (paroxysmal
or sustained), and patients transferred from another ICU with prior septic
shock.
Intervention: After inclusion, all patients were equipped with long-dura-
tion Holter ECG monitoring for 7 days. Measurements and Main Results:
NAF was defined as an AF episode lasting more than 30 seconds. Patient
characteristics, infection criteria, cardiovascular parameters, severity of ill-
ness, medical and technical support therapies were recorded. 
Among 66 patients, 29 (44%) developed NAF; 10 of which (34%) would
not have been diagnosed without Holter ECG monitoring. NAF patients were
older, and more often presented markers of heart failure, i.e. higher troponin
and NT-pro-BNP levels associated with lower left ventricular ejection fraction
(LVEF), as compared to patients who remained in sinus rhythm. NAF patients
also had longer QRS duration and more often presented nonsustained supra
ventricular arrhythmias (<30s) on the first day. In a multivariate model, only
age (OR: 1.06; p=0.01) and LVEF<45% (OR: 13.01, p=0.03) remained asso-
ciated with the occurrence of NAF. However, NAF was not an independent
predictor of 28 or 90 day mortality. 
Conclusion: This is the first study to examine the exact incidence and
risk factors of NAF in septic shock patients. NAF is common, especially
in older patients, and is associated with low ejection fraction. We did not
find NAF to be independently associated with higher mortality in this
study 
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Long-term success with magnetic navigation catheter ablation in
patients with persistent and longstanding persistent atrial fibrillation
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Introduction: Different techniques in catheter ablation (CA) of persistent
(Pers) and longstanding (LS) Pers AF have been described with variable out-
comes. We report long-term results in a series of Pers AF patients who under-
went CA with magnetic navigation (MN).
Methods: We prospectively included 50 patients (pts; 43 males;
61±10 y) referred for CA of Pers AF. Pers and LS Pers AF were defined
according to published guidelines. Freedom from AF is defined as the
absence of symptomatic or ECG/Holter documented AF after ablation. All
pts underwent stepwise CA using MN: circumferential pulmonary veins
isolation, bi-atrial complex fragmented electrograms ablation, roof ± left
isthmus ± cavo-tricuspid isthmus lines. Atrial tachycardia (AT) occurring
during CA were also targeted.
Results: Total duration of AF history was 56±42m (range 4 m-12 y,
median 48m). Mean duration of continuous AF was 8±12m (range 1-84m,
median 5.5m; 18% LS and 82% Pers AF). AF was lone in 50%. LA size
was 30±5cm2, CT-scan volume 139±51ml. Procedures' duration was
256±56 minutes with a fluoroscopy time of 13±5 min. RF time was
47±27 min. AF stopped without electrical cardioversion in 17 pts (34%;
sinus rhythm in 8 and AT in 9). A redo CA for recurring AF was per-
formed in 6 pts (12%). Complications (4 pts) resolved w/o sequellae: acute
coronary syndrome (1), pericardial effusion (1), AV fistula (1) and intra-
alveolar haemorrhage (1). After 19.9±9.5m (range 6-40, median 17.5m),
with 1.1 procedures/pt, 40 pts (80%) had no AF recurrence, of which 28
were off AAD and 12 remained on AAD. Incidence of postablation AT
was 12% (6/50).
Conclusion: Magnetic navigation for Pers AF ablation yields excellent
(80%) long-term (20m) prevention of AF recurrence (figure next page).
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How to identify a risk for subsequent atrial fibrillation and higher risk
of stroke in patients with hospitalization related to a cardiac cause?
Laurent Fauchier (1), Christele Pelade (2), Cecile Collignon (2), Emma-
nuelle Nicolle (2)
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A substantial part of ischemic strokes (IS) occurs in patients with atrial
fibrillation (AF) and 20% of all strokes are attributed to AF. We aimed to
identify patients with a cardiac condition without diagnosed AF at higher risk
of having a subsequent diagnosis of AF.
Methods: In a French longitudinal cohort study based on the PMSI data-
base covering hospital care for the entire population, we analyzed incidence
rates of new onset AF.
Results: Of 1,081,969 patients with hospitalization due to a cardiac condi-
tion in 2009, 826,416 patients did not have AF in their history but had hyper-
tension (51%), heart failure (24%), coronary artery disease (40%), rhythm or
conduction disturbances with no AF (23%), and/or valve disease (9%). A total
of 61,062 (7.4%) of these patients were diagnosed as having AF during a
follow-up of 17±15 months (yearly AF incidence rate 5.19%). CHA2DS2-
VASc score was higher in these patients (4.63±1.66 vs 2.83±1.98 in those
with no AF during FU, p<0.0001). Among these 61,062 patients, 3,623 (5.9%)
also suffered stroke during follow-up and CHA2DS2-VASc score was even
higher in these patients (5.29±1.60 vs 4.59±1.65 in those with AF and no
stroke during FU, p<0.0001). Among them, 967/3,623 (27%) had a stroke
before AF was diagnosed.
Conclusion: A cardiac condition was associated with a substantial risk of
AF (and stroke) during FU when CHA2DS2VASc score was higher. 
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Increased intracardiac VEGF and VWF levels revealed low grade
inflammatory process and progressive endothelial damage in patients
with atrial fibrillation
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Aims: Endothelial dysfunction seems to play a pivotal role in atrial fibril-
lation (AF). The purpose of this study was to investigate the relationship
between AF and vascular endothelial growth factor (VEGF) and to investigate
the effect of different clinical forms of AF on plasma concentration of Von
Willebrand Factor (vWF) at different levels of circulatory tree, both intracar-
diac and extracardiac. 
Methods and results: Peripheral (Pf), left atrial (LA), and coronary
sinus (CS) blood samples were obtained during cardiac catheterization
from 52 patients with paroxysmal AF (PAF), 36 with persistent AF
(PsAF), and 17 control subjects (Ct) with Wolff-Parkinson-White syn-
drome. Plasma levels of VEGF and vWF were measured at the three sam-
pled sites. Peripheral VEGF levels were higher in both PAF and PsAF
patients than in controls (P≤0.03). Left atrial VEGF levels were higher in
paroxysmal AF (P = 0.05), but not in persistent AF (P = 0.32), compared
with controls. Coronary sinus and pulmonary vein VEGF levels did not
differ significantly among groups. (Fig 1). Compared with Ct, patients
with PAF had higher LA plasma levels of vWF (P=0.004), but similar Pf
and CS levels (both P > 0.30). In contrast, patients with PsAF had higher
plasma concentrations of vWF in Pf (P=0.04), LA (P<0.001), and CS
(P=0.04) samples compared with Ct. Left atrial plasma concentrations of
vWF in patients with PsAF were also higher than in the PAF group
(P=0.04). (Fig 1, next page). 
Conclusion: This study suggests that inflammatory process in AF is of low
grade. The heart itself is the most likely source of high left atrial VEGF; how-
ever, this disorder appears to be a transient event in AF history.
AF patients presented significantly higher plasma concentrations of vWF.
This study suggests an association between the clinical evolution of AF and
the progression of endothelial dysfunction. Further studies will have to estab-
lish the exact mechanisms that link endothelial dysfunction and stroke in the
context of AF. 
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Obesity and new-onset atrial fibrillation in acute myocardial infarc-
tion: a gender specific risk factor
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Purpose: In spite of the widespread use of contemporary therapies, new-
onset atrial fibrillation (AF) in acute myocardial infarction (AMI) remains
common and associated with worse prognosis. No study have addressed obe-
sity, a modifiable risk factor, as a determinant of new-onset AF in AMI, 
Methods: 1123 consecutive patients admitted for AMI were prospectively
included. Obesity was defined as a BMI ≥30kg/m² Patients with a history of
AF or atrial ﬂutter were excluded. AF was considered either at AMI presenta-
tion or any time during hospital stay. Echocardiographic assessment of left
atria (LA) dimensions and left ventricular ejection fraction (LVEF) were per-
formed on admission.
Results: 91 (8%) patients developed new-onset AF. By multivariate ana-
lysis, several factors were independently associated with the occurrence of
new-onset AF: age (OR(95%CI): 1.06(1.04-1.09); p<0.001), obesity (OR:
2.11; 95% CI 1.22-3.54; p=0.007), LA indexed volume (OR(95% CI):
1.02(1.01-1.04); p=0.016), LVEF<40% (OR(95% CI): 1.91 (1.06-3.46);
p=0.032) and severe heart failure on admission (OR(95% CI): 2.46(1.21-5.02);
p=0.013). In stratified analysis, we found marked differences in risk factors
for AF according to gender. In women, only age (OR (95% CI): 1.07(1.03-
1.11); p<0.001) and severe heart failure on admission (OR (95% CI):
4.02(1.38-11.7); p=0.011) were independently associated with AF. In contrast,
in men, age (OR(95% CI): 1.07(1.04-1.10); p<0.001), CRP>10mg/l (OR(95%
CI): 2.81(1.49-5.28); p=0.001), LA indexed volume (OR(95% CI): 1.03(1.01-
1.05); p=0.011) and obesity (OR: 2.50; 95% CI 1.26-4.97; p=0.009) were
independent correlates of AF. 
Conclusion: The present study suggests for the first time that obesity is a
major risk factor for the development of AF after AMI, which is specific to
men. These findings may have clinical implication for risk stratification in
AMI. 
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